Methods for monitoring and evaluating processes and outcomes

International Journal of Risk and Safety in Medicine

Volumn 15, Issue 1-2, 2002, Pages 55-66

  Mrazek, Monique F ^a   Mossialos, Elias ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG MONITORING; DRUG QUALITY; DRUG SURVEILLANCE PROGRAM; ECONOMIC EVALUATION; HEALTH CARE QUALITY; OUTCOMES RESEARCH; POLICY; PROCESS DESIGN; REVIEW; RISK ASSESSMENT;

EID: 0036968935     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. L.A. Aday, C.E. Begley, D.R. Lairson and C.H. Slater, Evaluating the medical care system: effectiveness, efficiency and equity, Foundation of the American College of Healthcare Executives, Ann Arbor, Michigan, 1993.
2. Audit Commission, A prescription for improvement: Towards more rational prescribing in general practice, HMSO, London, 1994.
3. R.H. Brook and E.A. McGlynn, Maintaining quality of care, in: Health Services Research, E. Ginzberg, ed., Harvard University Press, Cambridge, 1991.
4. P. Brudon-Jakobowictz, J.-D. Rainhorn and M.R. Reich, Model Indicators for Monitoring National Drug Policies, World Health Organization, Geneva, 1995.
5. E.A. Chrischilles and K. Gondek, Do practice guidelines augment drug utilisation review?, Pharmacoeconomics 12(6) (1997), 648-666.
6. A.J. Culyer and A. Wagstaff, Equity and equality in health and health care, Journal of Health Economics 12 (1993), 431-457.
7. M.F. Drummond, Experimental versus observational data in the economic evaluation of pharmaceuticals, Medical Decision Making 18(2) (1998), Suppl. S12-S18.
8. M.N.G. Dukes, Introduction, in: Drug Utilisation Studies - Methods and Uses, M.N.G. Dukes, ed., WHO Regional Office for Europe, Copenhagen, 1993.
9. P. Dunleavy, So, what do political scientists do?, New Statesman 9 (9 October 1998), 3-5, 31.
10. L. Greenfield, B.D. Colen, P.D. Cleary and S. Greenfield, Evaluating the Quality of Health Care: What Research Offers Decision Makers, Milbank Memorial Fund, New York, 1996.
11. I.C. Gyssens and B.J. Kullberg, Improving the quality of antimicrobial drug use can result in cost containment, Pharmacy World & Science 17 (1995), 163-167.
12. H. Hansluwka, Measuring the health of populations: Indicators and interpretations, Social Science and Medicine 20 (1985), 1207-1224.
13. W.W. Holland, Evaluation of Health Care, Oxford University Press, Oxford, 1983.
14. M. Johannesson, B. Joensson and G. Karlsson, Outcome measurement in economic evaluation, Health Economics 5(4) (1996), 279-296.
15. D.M. Krumholz, S.D. Jaanus and R.L. Urquidi, Prescribing patterns of optometrists newly licensed in therapeutic drug use in New York State, Optometry 72(5) (2001), 292-298.
16. J. Le Grand, Equity and Choice: An Essay in Economics and Applied Philosophy, HarperCollins Academic, London, 1991.
17. C.R. MacIntyre, D. Sindhusake and G. Rubin, Modelling strategies for reducing pharmaceutical costs is hospital, International Journal of Quality in Health Care 13(1) (2001), 63-69.
18. Management Science for Health, Managing Drug Supply, Kumarian Press, West Hartford, Connecticut, 1997.
19. A. Mant, W.C. Rotem, L. Kehoe and K.I. Kaye, Compliance with guidelines for continuity of care in therapeutics from hospital to community, Medical Journal of Australia 174(6) (2001), 277-280.
20. A. Maynard and T.A. Sheldon, Health economics: Has it fulfilled its potential?, in: Non-random Reflections on Health Services Research: On the 25th Anniversary of Archie Cochrane's Effectiveness and Efficiency, A. Maynard and I. Chalmers, eds, The Nuffield Provincial Hospitals Trust, London, 1997.
21. E.J. Mishan, Cost Benefit Analysis, 4th edn, Routledge, London, 1988.
22. A.S. St Leger, H. Schnieden and J.P. Walsworth-Bell, Evaluating Health Services' Effectiveness, Open University Press, Milton Keynes, 1992.
23. C.D. Shaw, Health-care league tables in the United Kingdom, Journal of Quality in Clinical Practice 17 (1997), 215-219.
24. C.C. Veninga, P. Denig, L.G. Pont and F.M. Haaijer-Ruskamp, Comparison of indicators assessing the quality of drug prescribing for asthma, Health Services Research 36(1 Pt 1) (2001), 143-161.
25. World Health Organisation, Quality Assurance in Health Care, Vol. 1, No. 2/3, WHO, Geneva, 1989.
26. World Health Organisation/Action Programme on Essential Drugs, How to investigate drug use in health facilities: Selected drug use indicators, WHO/DAP, Geneva, 1993.